AQA
MED icon

Alpha Quant Advisors’s Medifast MED Stock Holding History

Alpha Quant Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$18K Buy
138
+21
+18% +$2.66K 0.02% 185
2018
Q4 		$15K Buy
+117
New +$20K 0.02% 195

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Alpha Quant Advisors's MED Position: Q1 2019 in Review

Alpha Quant Advisors increased its Medifast (MED) stake by 18% in Q1 2019, buying an estimated $2.66K and bringing the position to 138 shares worth $18K. The position accounts for 0.02% of the portfolio, ranked #185.

Alpha Quant Advisors first reported a position in MED in Q4 2018 and has held it in 2 quarters since. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • Alpha Quant Advisors held 138 shares of Medifast worth $18K as of Q1 2019.
  • Alpha Quant Advisors bought 21 Medifast shares in Q1 2019, an estimated $2.66K.
  • Medifast made up 0.02% of Alpha Quant Advisors's portfolio in Q1 2019, its #185 holding.
  • Alpha Quant Advisors first reported a position in Medifast in Q4 2018 and has held it in 2 quarters since.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.